Tag: chemistry
-
Trial Shows Clot Prevention Drug Safe, Reversible
18 December 2015. An early-stage clinical trial of an experimental drug to prevent blood clots during heart surgery shows the drug prevents platelet accumulation, while still safe and temporary to prevent excess bleeding. The study by a team at Tufts University Medical Center in Boston and Sinai Hospital of Baltimore appears in yesterday’s issue of…
-
Nanotech Multi-Drug Delivery Technique Devised for Cancer
10 December 2015. A pharmacy lab at Oregon State University developed a technique for combining three drugs into nanoscale particles that treat melanoma spreading to lymph nodes in lab animals. The team led by Oregon State pharmacy professor Adam Alani published its proof-of-concept findings last month in Journal of Controlled Release (paid subscription required). Alani’s…
-
University Spin-Off Develops Pain Killer Patch
8 December 2015. A new company begun by a chemistry professor in the U.K. is developing a patch infused with ibuprofen for people needing relief from pain or inflammation from arthritis. Medherant Ltd., in Coventry, is developing the patch based on research at University of Warwick conducted by David Haddleton, who founded the company and…
-
Implanted Sensor to Measure Blood Sugar in Development
1 December 2015. An engineering group at University of Texas in Arlington is developing a system for people with diabetes to measure their blood glucose levels without taking repeated blood drops throughout the day. The work in the lab of biomaterials professor Kyungsuk Yum is funded by a $100,00 grant from the Texas Medical Research Collaborative.…
-
ARPA-E Funding 41 Energy Generation, Efficiency Projects
23 November 2015. Advanced Research Projects Agency-Energy, or ARPA-E, the agency funding riskier energy research and development initiatives in the U.S., announced funding for 41 new projects, including those at 19 private companies. The grants totaling $125 million were revealed today by Secretary of Energy Ernest Moniz at 1776, a technology incubator and seed fund…
-
Chip Device Removes Nanoparticles from Plasma
23 November 2015. A team from University of California in San Diego used a miniature electronic chip to quickly separate nanoparticles for delivering drugs from blood plasma. The process, with a technology developed in the engineering lab of Michael Heller at UC-San Diego and licensed to a spin-off company from the university, is described in…
-
FDA Approves Nasal Spray for Opioid Overdose
20 November 2015. The U.S. Food and Drug Administration this week approved the first formulation of a current drug to treat opioid overdose in nasal spray form. The Narcan nasal spray is made by Adapt Pharma Ltd., a company headquartered in Dublin, Ireland. Opioids work by reducing the intensity of pain signals to the brain, particularly…
-
Nanotech Sensors Devised for RNA Cancer Detection
17 November 2015. Biochemical and medical researchers developed a technique for sensitive detection of RNA in humans that in lab tests can distinguish between benign conditions and cancer. The team from the lab of chemistry professor Rajesh Sardar at Indiana University-Purdue University Indianapolis published its findings in this month’s issue of the journal ACS Nano.…
-
Electronic Patch Shown to Kill Drug-Resistant Bacteria
11 November 2015. Washington State University engineers and medical researchers developed an electronic stimulation patch that in lab tests kills nearly all drug-resistant bacteria it contacts. The team from the lab of bioengineering professor Haluk Beyenal published its proof-of-concept findings in a recent issue of the journal Scientific Reports. Beyenal’s lab in Pullman, Washington studies…
-
Start-Up’s Air Quality Technology to Clean City Areas
10 November 2015. A start-up company is licensing research from University of Copenhagen in Denmark to develop a technology for removing air pollution from city neighborhoods. The air cleaning technology, known as gas phase advanced oxidation, is a product of the atmospheric chemistry lab led by Matthew Johnson, who also serves as chief scientist for…